Chloroquine and hydrocychloroquine have been evaluated in 30 noninfectious disorders and conditions other than rheumatoid arthritis or lupus erythematosus; 12 of these have been subjected to well-designed controlled trials. It is concluded that chloroquines are safe and effective first line therapies for selected patients with porphyria cutanea tarda, cutaneous sarcoidosis, cutaneous manifestations of dermatomyositis, hyperlipidemias and thromboembolic prophylaxis for patients with antiphospholipid antibodies. Published experience with these and other diseases or syndromes are critically reviewed.
BenyenAC.can chloroquine be of value in the treatment of hypercholesterolemia?Artery1986; 13: 340–351.
2.
WallaceDJ. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids,Amer J Med1990; 89: 322–326.
3.
HodisHN, QuismorioFP, WichkamE, BlankenhornDB.The lipid, lipoprotein and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythromatosus,J Rheumatol1993; 20: 661–65.
4.
BlythTH, McDonaldAG, CapellHA, HunterJA.A comparison of hydroxychloroquine and myocrisin in rheumatoid arthritis (RA); does hydroxychloroquine have a favorable effect on the blood lipid profile?Brit J Rheumatol1994; 33 (Suppl.): 149.
5.
PowrieJK. Effects of chloroquine on the dyslipidemia of non-insulin dependent diabetes mellitus,Metabolism1993; 42: 415–419.
6.
PowrieJK, WattsGF, SonksenPH, JonesRH.Short-term effects of mepacrine on serum lipids, liproproteins, and apolipoproteins in patients with non-insulin-dependent diabetes mellitus,Metabolism1994; 43: 131–134.
7.
PetriM, LakattaC, MagdarL, GoldmanD.Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis,Amer J Med1994; 96: 254–259.
8.
JancinovaV, NosalR, PterikovaM.On the inhibitory effect of chloroquine on blood platelet aggregation.Thromb Res1994; 74: 495–504.
9.
CecchiE, FerrarisE.Desludging action of hydroxychloroquine in rheumatoid arthritis.Acta Rheum Scand1962; 8: 214–221.
10.
LoudonJR.Hydroxychloroquine and postoperative thromboembolism after total hip replacement.Amer J Med1988; 84 (Supp. 4A): 57–61.
WallaceDJ, Linker-IsraeliM, MetzgerAL, StecherVJ.The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE,Lupus1993; 2: S13–S15.
13.
PetriM. Arterial thrombotic events (TE) in SLE: The Baltimore Lupus Cohort Study,Arthritis Rheum1994; 37: S297.
ZicJA, HorowitzDH, ArzubiagaC, KingLE.Treatment of cutaneous sarcoidosis with chloroquine,Arch Dermatol1991; 127: 1034–1040.
16.
MorseSI, CrohnZA.Hirsch JG, Shaedler RW. The treatment of sarcoidosis with chloroquine.Amer J Med1961; 30: 779–784.
17.
HirschJG.Experimental treatment with chloroquine.Am Rev Respir Dis1961; 84: 52–58.
18.
DaviesD.Sarcoidosis treated with chloroquine.Br J Dis Chest1963; 57: 30–36.
19.
SiltzbachLE, TeirsteinAS.Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis.Acta Med Scand1964; 176 (Suppl. 425): 302–308.
20.
MorseSI.The therapeutic effect of chloroquine in sarcoidosis, In: TuriafJ, ChabotJ (eds). La Sarcoidoise: Rapports de la IV Conference International, Paris, France. Mason & Co, 1967; 755–771.
21.
British Tuberculosis Association.Chloroquine in the treatment of sarcoidosis: a report of the research committee of the British Tuberculosis Association,Tubercle1967; 48: 257–272.
22.
BrodthagenH, GligI.Hydroxychloroquine in the treatment of sarcoidosis. In: TyriafJ, ChabotJ eds). La Sarcoidoise: Rapports de la IV Conference International, Paris, France. Mason & Co, 1967: 764–767.
23.
JohnsCJ. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy: outcome and complications,Ann NY Acad Sci1986; 465: 702–712.
24.
JonesE, CallenJP.Hydroxychloroquine in effective therapy for control of cutaneous sarcoidal granuloma,J Am Acad Dermatol1990; 23: 487–489.
25.
Abu-SkakraM, LeeP.Hypoglycemia: an unusual adverse reaction to chloroquine.Clin Exper Rheumatol1994; 11: 95–96.
26.
WhiteNJ. Hypoglycemia in african children with severe malaria.Lancet1987; 1: 708–711.
27.
QuartaroA, ConsoliG, CerielloA, GiuglianoD.Is there a role of chloroquine treatment in diabetes? A three case report.Diabete & Metabolisme1988; 14: 666–667.
28.
QuartaroA. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes. An old job for a new drug?Annals Intern Med1990; 112: 678–681.
29.
PowrieJK. Mode of action of chloroquine in patients with non-insulin dependent diabetes mellitus.Am J Physiol1991; 260 (6 Pt 1): E897–E904.
30.
PetriM, FermanD, GoldmanD.Hypoglycemic effect of hydroxychloroquine in systemic lupus erythematosus.Arthritis Rheum1994; 37: R24.
31.
CainelliT. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda,Brit J Dermatol1983; 108: 593–600.
GeschicterCF.Quinoline therapy in asthma.Southern Med J1955; 48: 497–509.
35.
GoldsteinJA.Hydroxychloroquine in asthma.Amer Rev Resp Dis1983; 128: 1100–1101.
36.
CharousBL.Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma.Annals Allergy1990; 65: 53–58.
37.
FoxRI. Treatment of primary Sjogren's syndrome with hydroxychloroquine.Amer J Med1988; 85 (Suppl. 4A): 62–67.
38.
KruizeAA. Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial.Annals Rheum Dis1993; 52: 360–364.
39.
MurphyGM, HawkJL, MagnusJA.Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring.Brit J Deramtol1987; 116: 379–386.
40.
ParrowA, SamuelssonS-M.Chloroquine for leg cramps.Acta Med Scand1967; 181: 237–244.
41.
SeverMS, KocakN.Chloroquine phosphate reduces the frequency of muscle cramps during maintenance hemodialysis.Nephron1990; 56: 441.
42.
RothschildBM.Prospective six month, double-blind trial of Plaquenil treatment of calcium pyrophosphae (sic) deposition disease (CPPD), Arthritis Rheum1994; 37: S414.
43.
DoringH-F, Mullejans-KreppelU.Treatment of atopic dermatitis with chloroquine.Z Hautkr1987; 62: 1205–1213.
44.
SmithKC.Hydroxychloroquine is useful in the management of atopic dermatitis.Brit J Dermatol1992; 126: 93–94.
45.
EisenD.Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial.J Amer Acad of Dermatol1993; 28: 609–612.
46.
AllbersSE, GlassLF, FenskeNA.Lichen planus subtropicus: Direct immunofluorescence and therapeuric response to hydroxychloroquine.Inter J Dermatol1994; 33: 645–647.
47.
WakelinSH, JamesMP.Extensive lichen sclerosis et atrophicus with bullae and ulceration—improvement with hydroxychloroquine.Clin Exper Dermatol1994; 19: 332–334.
48.
CarlinMC, RatzJL.A case of generalized granuloma annulare responding to hydroxychloroquine.Cleveland Clin J Med1967; 54: 229–232.
49.
Cleveland Clin J Med1968; 55: 117.
50.
SayersME, MazanecDJ.Use of antimalarial drugs for the treatment of psoriatic arthritis.Amer J Med1992; 93: 474–475.
51.
KuflikEG.Effect of antimalarial drugs on psoriasis.Cutis1980; 26: 153–155.
52.
KammerGM, SoterNA, GibsonDJ, SchurPH.Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients.Semin Arthritis Rheum1979; 9: 75–97.
53.
Le GuennecP. Management of giant cell arteritis. Value of synthetic antimalarial agents, A retrospective study of 36 patients.Rev Rhum (Eng Ed)1994; 61: 423–428.
54.
WooTY. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.J Am Acad Dermatol1984; 10: 592–600.
55.
JamesW, DawsonN, RodmanO.The treatment of dermatomyositis with hydroxychloroquine.J Rheumatol1985; 12: 1214–1216.
56.
BloomBJ. Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy.J Rheumatol1994; 21: 2171.
57.
OlsonNY, LindsleyCB.Adjunctive use of hydroxychloroquine in childhood dermatomyositis.J Rheumatol1989; 16: 1545–1547.
58.
OlsonNY, LindsleyCB.Drs Olson and Lindsley reply.J Rheumatol1994; 21: 2171–2172.
59.
YoussefW, YanA, RussellAS.Palindromic rheumatism: A response to chloroquine.J Rheumatol1991; 18: 35–37.
60.
GoldingDN.D-pencillamine in palindromic rheumatism.Brit Med J1976; 2: 1382–1383.
61.
MattingleyS. Palindromic rheumatism.J R Coll Phys1981; 15: 119–123.
62.
HannonenP, MottonenT, OkaM.Palindromic rheumatism, a survey of 60 patients.Scand J Rheumatol1967; 16: 413–420.
63.
McKayJ, CervantesA, SingletonPTJr. Hydroxychloroquine sulfate: An effective alternative in treating palindromic rheumatism.Arthritis Rheum1981; 24: S70.
64.
RobertsonCR, RiceJR, AllenNB.Treatment of erosive osteoarthritis with hydroxychloroquine.Arthritis Rheum1993; 36: S167.
65.
BryantLR, des RosierKF, CarpenterMT.Hydroxychloroquine in the treatment of erosive osteoarthritis.J Rheumatol1995; 22: 1527–1531.
OchoniskyS. Granulomatous cheilitis as a cutaneous extension of Crohn's disease responds to hydroxychloroquine.Ann Dermatol Venereol1992; 119: 844–846.
73.
LouisE, BelaicheJ.Hydroxychloroquine (Plaquenil) for recurrence prevention of Crohn's disease after curative surgery.Gastroenterol Clin Biol1995; 19: 233–234.
74.
AdamsJS, DizBS, SharmaOP.Effective reduction in the serum 1, 25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcaemia with short-course chloroquine therapy.Annals Intern Med1989; 111: 437–438.
75.
DatarSA, PriessJR.Hydroxychloroquine in the treatment of hypercalcemia secondary to disseminated coccidiomycosis.Clin Res1994; 42: A17.
76.
O'LearyTJ. The effects of chloroquine on serum 1, 5-dihydroxyvitamin D and calcium metabolism in sarcoidosis.N Engl J Med1986; 315: 727–730.
77.
BarrePE, Gascon-BavreM, MeakinsJL, GoltzmanD.Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis.Amer J Med1987; 82: 1259–1262.
78.
HaubenM.Quinacrine and chronic fatigue syndrome.Amer Fam Phys1994; 49: 1354.
79.
StollDM.Treatment of cutaneous pseudolymphoma with hydroxychloroquine.J Amer Acad Dermatol1983; 8: 696–699.
80.
DrenouB, GuyaderD, TurlinB, FauchetR.Treatment of sideroblastic anemia with chloroquine.N Engl J Med1995; 332: 614.
81.
CoblynJS, TaylorP.Treatment of chronic lyme arthritis with hydroxychloroquine.Arthritis Rheum1981; 24: 1567–1569.
82.
LopezLR, DavisKC, KohlerPF, SchocketAL.The hypocomplementemic urticarial-vasculitis syndrome: Their response to hydroxychloroquine.J Allergy Clin Immunol1984; 73: 600–603.
83.
BaloghE, Nagy-VezekenyiK, ForizsE.REM syndrome: An immediate therapeuric response to hydroxychloroquine sulphate.Acta Derm Venereol 180; 60: 173–175.
84.
HymesSR, JordonRE.Pemphigus foliaceus. The use of antimalarial agents as adjuvant therapy.Arch Dermatol1992; 128: 1462–1464.
85.
PurcellJJ.Hydroxychloroquin (sic) and chronic sinusitis.Conn Med1990; 54: 694.
86.
BrawerAE.Anarthritic rheumatoid arthritis: The polymyalgia dilemma.Arthritis Rheumatism1991; 34: S179.
87.
MayerL. Personal communication from Sanofi Winthrop.
